Leptospirosis presenting with cholestatic jaundice: Hepatic features and clinical outcomes
Hepatology Forum · 2026 · 7 (4) · 355-360
DOI: 10.14744/hf.2026.02126 ↗Abstract
Background and Aim: Leptospirosis is a zoonotic infection with a wide spectrum of clin-ical manifestations. Hepatic involvement is common, particularly in severe forms, such as Weil’s disease, and poses diagnostic and therapeutic challenges. Materials and Methods: We retrospectively evaluated the general characteristics and outcomes of patients diagnosed with leptospirosis at Harran University, Department of Gastroenterology between May 2019 and September 2025. Results: We included 30 patients (86.7% male) with a median age of 45 years (range: 18–78 years); the median total bilirubin at presentation was 9.1 mg/dL (range: 2.5–49.0 mg/dL). All patients showed features of moderate-to-severe liver injury. A total of 18 (60%) patients developed acute kidney injury, 10 (33.3%) had pulmonary involvement, myocarditis was identified in 3 (10%) patients, and 5 (16.7%) patients exhibited neuro-logical manifestations. All patients received antibiotics (doxycycline, cephalosporins, and carbapenems). Corticosteroids were given to nine patients. Therapeutic plasma exchange was performed in 12 (40%) patients. Seventeen (56.7%) patients required in-tensive care unit (ICU) admission, and 3 (10%) required invasive mechanical ventilation. Median creatinine (2.1 vs. 1.2 mg/dL, p=0.004) was higher, pulmonary involvement was more common (52.9% vs. 7.7%, p=0.017), plasma exchange (58.8% vs. 15.4%, p=0.026) and corticosteroid use (52.9% vs. 0%, p = 0.003) were more common among patients admitted to the ICU than among those not admitted to the ICU. Two (6.7%) patients did not respond to therapy and died during follow-up. Conclusion: Leptospirosis presenting with liver injury and pulmonary involvement is associated with a higher probability of ICU admission. Corticosteroids and/or plasma exchange can be used, but prospective studies are necessary to reveal their prognostic relevance in patients presenting with severe leptospirosis.
EUVIMED